News, Policy & Media


UK Summit on the role of Diagnostics - BIVDA to participate in Diagnostics Summit

The importance of In-Vitro Diagnostics within healthcare will be discussed in a UK Summit to be held on November 8th in London. The Summit, set to take place at The Wellcome Collection, will feature an array of leading experts across healthcare at both primary and secondary levels. The aim of the Summit, hosted by 4 All of us and BIVDA, is to place In-Vitro Diagnostics at the heart of the debate on preventative healthcare.

The Summit comes on the back of the recent Five Year Further Forward View, published in March by NHS England, cited the importance of diagnostics in delivering the governments health strategy of reducing admissions and increasing community care. Within the Review it was announced that by April 2018 10 new Rapid Diagnostic and Assessment Centres for Cancer treatment would be rolled out across England.

The Summit will address a range of key areas for which In-Vitro Diagnostics can be utilised ,Sexual Health, Antibiotic Resistance, Diabetes and Sepsis amongst others. Through a range of keynote presentations, workshops and case studies, the Summit will make the business case for investing in diagnostics to improve health outcomes. Speakers already confirmed to attend include:

Dr Ann Van den Bruel, Associate Professor, Department of Primary Care Health Sciences; Director of the NIHR Diagnostic Evidence Cooperative, Oxford

Rosanna W Peeling Professor and Chair, Diagnostic Research Director, International Diagnostics Centre London School of Hygiene & Tropical Medicine

Dr Daniel Lasserson GP and Senior Clinical Researcher, Department of Primary Care Health Sciences, University of Oxford

The Summit will welcome health professionals from a range of backgrounds including Microbiology, Pharmacy, General Practice, Laboratory, Nursing and Clinical. BIVDA are delighted to co-host the Summit alongside 4 All of us, who manage the Antibiotic Guardian Campaign alongside Public Health England. BIVDA members will also receive reduced admission to attend the Summit with tickets and further information available at


The Government's NHS Funding Bill, announced in the Queen's Speech, enters the House of Comm...

Read More >

 The House of Lords held its second reading of the Medicines and Medical Devices Bill last Thur...

Read More >

Trade deals by the UK Government with Japan and New Zealand are progressing in their negotiations. T...

Read More >

From 1 January 2021 the Medicines and Healthcare products Regulatory Agency (MHRA) will take on the ...

Read More >

Members can find attached a short briefing note outlining the Medicines and Medical Devices Bill whi...

Read More >

Finding solutions to the current testing service crisis is the Government’s ‘number one&...

Read More >